Mikko Joensuu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mikko Joensuu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jari Tiihonen
Karolinska Institutet
3 shared publications Johannes Lehtonen
Departments of Psychiatry
2 shared publicationsJyrki Kuikka
Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turun yliopisto
2 shared publicationsPasi Ahola
Departments of Psychiatry
2 shared publicationsRitva Vanninen
Clinical Radiology
2 shared publicationsTommi Tolmunen
Departments of Psychiatry
2 shared publications
Latest Publications
- Open Access
- 23 July 2010
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 64 (4) , 387-393
Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression
- 23 July 2010
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 64 (4) , 387-393
Open AccessSerotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression
- 1 February 2007
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 154 (2) , 125-131
Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [123I] nor-β-CIT SPECT imaging
- 1 February 2007
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 154 (2) , 125-131
Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [123I] nor-β-CIT SPECT imaging
- Open Access
- 13 September 2004
- Published by Springer Nature in BMC Psychiatry
- Vol. 4 (1) , 27
Elevated midbrain serotonin transporter availability in mixed mania: a case report
Background: Results obtained from brain imaging studies indicate that serotonin transporter (SERT) and dopamine transporter (DAT) densities are altered in major depression. However, no such studies have been published on current mania or hypomania. Case presentation: In this single photon emission computed tomography (SPECT) study with [123I]nor-β-CIT we present a case with simultaneous symptoms of major depression and hypomania. She had an elevated serotonin transporter availability (SERT) in the midbrain and elevated dopamine transporter availability (DAT) in the striatum, which normalised in a one-year follow-up period during which she received eight months of psychodynamic psychotherapy. Conclusions: To our knowledge, this is the first report on SERT and DAT associated with mania. In our case the availability of both SERT in the midbrain and DAT in the striatum were elevated at baseline and declined during psychotherapy, while the SERT and DAT of the depressed controls increased during psychotherapy. Symptoms of hypomania in the case were alleviated during psychotherapy. Clinical recovery was also reflected in the Hamilton Depression Rating Scale (HDRS) scores.
- 13 September 2004
- Published by Springer Nature in BMC Psychiatry
- Vol. 4 (1) , 27
Open AccessElevated midbrain serotonin transporter availability in mixed mania: a case report
Background: Results obtained from brain imaging studies indicate that serotonin transporter (SERT) and dopamine transporter (DAT) densities are altered in major depression. However, no such studies have been published on current mania or hypomania. Case presentation: In this single photon emission computed tomography (SPECT) study with [123I]nor-β-CIT we present a case with simultaneous symptoms of major depression and hypomania. She had an elevated serotonin transporter availability (SERT) in the midbrain and elevated dopamine transporter availability (DAT) in the striatum, which normalised in a one-year follow-up period during which she received eight months of psychodynamic psychotherapy. Conclusions: To our knowledge, this is the first report on SERT and DAT associated with mania. In our case the availability of both SERT in the midbrain and DAT in the striatum were elevated at baseline and declined during psychotherapy, while the SERT and DAT of the depressed controls increased during psychotherapy. Symptoms of hypomania in the case were alleviated during psychotherapy. Clinical recovery was also reflected in the Hamilton Depression Rating Scale (HDRS) scores.